Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

The Lancet Infectious Diseases

Volumn 20, Issue 5, 2020, Pages 565-574

  To, Kelvin Kai Wang ^a,b   Tsang, Owen Tak Yin ^c   Leung, Wai Shing ^c   Tam, Anthony Raymond ^d   Wu, Tak Chiu ^e   Lung, David Christopher ^e   Yip, Cyril Chik Yan ^a   Cai, Jian Piao ^a   Chan, Jacky Man Chun ^c   Chik, Thomas Shiu Hong ^c   Lau, Daphne Pui Ling ^c   Choi, Chris Yau Chung ^c   Chen, Lin Lei ^a   Chan, Wan Mui ^a   Chan, Kwok Hung ^a   Ip, Jonathan Daniel ^a   Ng, Anthony Chin Ki ^a   Poon, Rosana Wing Shan ^a   Luo, Cui Ting ^a   Cheng, Vincent Chi Chung ^a   Chan, Jasper Fuk Woo ^a,b   Hung, Ivan Fan Ngai ^f   Chen, Zhiwei ^a   Chen, Honglin ^a   Yuen, Kwok Yung ^b   more..

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG SHENZHEN HOSPITAL   (China)

^c PRINCESS MARGARET HOSPITAL   (Hong Kong)

^d QUEEN MARY HOSPITAL   (Hong Kong)

^e QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON BETA SERINE; LOPINAVIR PLUS RITONAVIR; NUCLEOPROTEIN; RIBAVIRIN; SURFACE SPIKE PROTEIN RECEPTOR BINDING DOMAIN; UNCLASSIFIED DRUG; VIRAL PROTEIN; VIRUS RNA; VIRUS ANTIBODY;

ADULT; AGE; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; ENZYME IMMUNOASSAY; FEMALE; HONG KONG; HUMAN; MALE; NANOPORE SEQUENCING; NONHUMAN; NOSE SMEAR; OBSERVATIONAL STUDY; OROPHARYNX; PRIORITY JOURNAL; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; THROAT CULTURE; VIRUS LOAD; WHOLE GENOME SEQUENCING; BETACORONAVIRUS; BLOOD; CORONAVIRUS INFECTION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LABORATORY TECHNIQUE; MIDDLE AGED; PANDEMIC; SALIVA; SEVERITY OF ILLNESS INDEX; VIROLOGY; VIRUS PNEUMONIA;

ADULT; AGED; ANTIBODIES, VIRAL; BETACORONAVIRUS; CLINICAL LABORATORY TECHNIQUES; CORONAVIRUS INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; SALIVA; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 85082924149     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(20)30196-1     Document Type: Article

References (32)

1. Chan, JF-W, Yuan, S, Kok, K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395 (2020), 514–523.
2. Chan, JF, Lau, SK, To, KK, Cheng, VC, Woo, PC, Yuen, KY, Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28 (2015), 465–522.
3. Cheng, VCC, Lau, SKP, Woo, PCY, Yuen, KY, Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 20 (2007), 660–694.
4. Peiris, JSM, Chu, CM, Cheng, VCC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 (2003), 1767–1772.
5. Chu, CM, Cheng, VC, Hung, IF, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59 (2004), 252–256.
6. To, KK-W, Tsang, OT-Y, Yip, CC-Y, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis, 2020 published online Feb 12. DOI:10.1093/cid/ciaa149.
7. Zhou, P, Yang, X-L, Wang, X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020 published online Feb 3. DOI:10.1038/s41586-020-2012-7.
8. Zou, L, Ruan, F, Huang, M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med, 2020 published online Feb 19. 10.1056/NEJMc2001737.
9. To, KKW, Yip, CCY, Lai, CYW, et al. Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study. Clin Microbiol Infect 25 (2019), 372–378.
10. To, KKW, Chan, KH, Ho, J, et al. Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study. Clin Microbiol Infect 25 (2019), 1539–1545.
11. To, KK, Lu, L, Yip, CC, et al. Additional molecular testing of saliva specimens improves the detection of respiratory viruses. Emerg Microbes Infect, 6, 2017, e49.
12. Chan, JF, Yip, CC, To, KK, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol, 2020 published online March 4. DOI:10.1128/JCM.00310-20.
13. Woo, PC, Lau, SK, Tsoi, HW, et al. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 363 (2004), 841–845.
14. Chen, LL, Wu, WL, Chan, WM, et al. Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains. Epidemiol Infect, 147, 2019, e279.
15. Chan, KH, Cheng, VC, Woo, PC, et al. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol 12 (2005), 1317–1321.
16. Oh, MD, Park, WB, Choe, PG, et al. Viral load kinetics of MERS coronavirus infection. N Engl J Med 375 (2016), 1303–1305.
17. Hayden, FG, Treanor, JJ, Fritz, RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 282 (1999), 1240–1246.
18. Wang, D, Hu, B, Hu, C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020 published online Feb 7. DOI:10.1001/jama.2020.1585.
19. Hung, IFN, To, KKW, Chan, JFW, et al. Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb/III trial. Chest 151 (2017), 1069–1080.
20. Chan, JF, Yao, Y, Yeung, ML, et al. Treatment With lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis 212 (2015), 1904–1913.
21. Nukoolkarn, V, Lee, VS, Malaisree, M, Aruksakulwong, O, Hannongbua, S, Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors. J Theor Biol 254 (2008), 861–867.
22. Chu, CM, Poon, LL, Cheng, VC, et al. Initial viral load and the outcomes of SARS. CMAJ 171 (2004), 1349–1352.
23. Chen, WJ, Yang, JY, Lin, JH, et al. Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms. Clin Infect Dis 42 (2006), 1561–1569.
24. Zhang, W, Du, RH, Li, B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 9 (2020), 386–389.
25. Zhang, L, Zhang, F, Yu, W, et al. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol 78 (2006), 1–8.
26. Liu, L, Wei, Q, Lin, Q, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight, 4, 2019, 123158.
27. Park, D, Huh, HJ, Kim, YJ, et al. Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus. Cold Spring Harb Mol Case Stud, 2, 2016, a001214.
28. Wang, WK, Chen, SY, Liu, IJ, et al. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis 10 (2004), 1213–1219.
29. Liu, L, Wei, Q, Alvarez, X, et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol 85 (2011), 4025–4030.
30. Guan, W, Ni, Z, Hu, Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020 published online Feb 28. DOI:10.1056/NEJMoa2002032.
31. Lu, R, Zhao, X, Li, J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395 (2020), 565–574.
32. Che, XY, Qiu, LW, Liao, ZY, et al. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. J Infect Dis 191 (2005), 2033–2037.